199634 Implementation of a portable cholinesterase monitoring kit in a clinical setting: A Normalization Process approach

Sunday, November 8, 2009

Randy J. Treadwell, MPHc , Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA
Matthew Keifer, MD, MPH , Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA
Since 2004 Washington State has maintained a cholinesterase (ChE) monitoring program for farm workers who are exposed to organophosphate (OP) and n-methyl-carbamate pesticides as part of their employment duties. This study implements the Normalization Process Model (NPM) developed by May et al. to identify factors related to work that may favor or inhibit routine embedding of a portable ChE monitoring kit into clinical practice. Surveys were conducted in an attempt to capture the perceptions of the current monitoring program in the Yakima Valley from those most involved with it: growers/employers, farm workers, and healthcare staff at an occupational medical clinic that handles the majority of ChE monitoring for the region. The survey also attempted to capture how amenable stakeholders would be to possible introduction of a new monitoring system that would include the portable ChE monitoring kit. The perception data was obtained through oral interviews and was used to characterize the constructs of the NPM theory. These constructs serve as organizational tools for assessing the potential embedding of the ChE kit within the clinic. Data analysis is ongoing with results to be reported at the annual meeting. The ultimate goal of this project is to assess how to introduce a cholinesterase monitoring kit into clinical practice in a manner that best assures the success of initial and sustainable adoption.

Learning Objectives:
1. Identify factors related to work that may favor or inhibit routine embedding of a portable cholinesterase monitoring kit into clinical practice. 2. Evaluate the perceptions of involved clinicians, growers, and pesticide handlers regarding the current ChE monitoring program in Washington State. 3. Assess how amenable the current climate is to possible adoption of a new monitoring program which includes the portable ChE monitoring kit. 4. Identify issues that can be modified, augmented or attenuated in order to best assure initial and sustainable adoption of a ChE monitoring kit into clinical practice.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Completed graduate level courses in toxicology and health services. MPH thesis work for the previous two years has included research into pesticide toxicology, the current cholinesterase monitoring program in Washington State, and qualitative data analysis in order to provide accurate and precise study results.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.